Forefront Videos

What’s a Quasi-Experiment?…and Why Should I Care?

Michael Law, Ph.D.
Centre for Health Services and Policy Research
The University of British Columbia
Vancouver, Canada

Harnessing HIV-specific T cells to eliminate latent viral reservoirs

Mark A. Brockman, PhD
Associate Professor and Canada Research Chair, Simon Fraser University
Associate Scientist, BC Centre for Excellence in HIV/AIDS

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search